Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05919511 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Study acronym: THRIVE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial sites expanded: 32 → 37 locations Eligibility criteria expanded, about 5 words Show 1 more changeShow less
    • Eligibility criteria expanded, about 5 words
  2. 2 versions Re-verified since Mar 20, 2026, no change to tracked fieldsv14-v15
  3. Study sites: 28 to 32 Start date: Aug 2, 2023 to Aug 1, 2023v13 Show 1 more changeShow less
    • Start date: Aug 2, 2023 to Aug 1, 2023
  4. Study sites: 25 to 28v12
  5. Study Status, Referencesv11
Show 9 earlier versionsHide 9 earlier versions
  1. Study sites: 22 to 25v10
  2. Study sites: 18 to 22v9
  3. Study sites: 13 to 18v8
  4. Study sites: 10 to 13v7
  5. Study sites: 8 to 10v6
  6. Study sites: 5 to 8v5
  7. Study sites: 2 to 5v4
  8. Start date changed from estimate of Aug 14, 2023 to Aug 2, 2023v3
  9. Trial status: Not Yet Recruiting to Recruiting Start date: Jun 26, 2023 to Aug 14, 2023 · Study sites: 0 to 2v2 Show 2 more changesShow less
    • Start date: Jun 26, 2023 to Aug 14, 2023
    • Study sites: 0 to 2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Incyte
94 trials monitored
See 9 trials at risk
The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)
Trial Details
NCT Number NCT05919511
Lead Sponsor Incyte Corporation
Conditions cGVHD
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov